Product NDC: | 55390-219 |
Proprietary Name: | Methylprednisolone Sodium Succinate |
Non Proprietary Name: | Methylprednisolone Sodium Succinate |
Active Ingredient(s): | 1 g/8mL & nbsp; Methylprednisolone Sodium Succinate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-219 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040641 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070301 |
Package NDC: | 55390-219-01 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 BOX (55390-219-01) > 8 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 55390-219-01 |
Proprietary Name | Methylprednisolone Sodium Succinate |
Package Description | 1 VIAL, SINGLE-DOSE in 1 BOX (55390-219-01) > 8 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 55390-219 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Methylprednisolone Sodium Succinate |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20070301 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | METHYLPREDNISOLONE SODIUM SUCCINATE |
Strength Number | 1 |
Strength Unit | g/8mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |